Financials
- Market Capitalization 32.19 B
- Employee 2 500
- Founded 2002
- CEO Yvonne Greenstreet
- Website www.alnylam.com
- Headquarter Massachusetts, United States
- FIGI BBG000BFGNJ5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
56.06
Fiyat/satışlar oranı
8.6
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 279 | MRNA Moderna, Inc. - Common Stock | 148.95 USD | +6.14% | -5.38% | +171.16% | +522.44% | 59.47 B USD | ||
| 352 | RVMD Revolution Medicines, Inc. - Common Stock | 208.36 USD | +1.36% | -1.15% | +12.98% | +276.10% | 44.66 B USD | ||
| 482 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.86 USD | +0.73% | -0.69% | +6.54% | +66.02% | 27.63 B USD | ||
| 493 | INSM Insmed Incorporated - Common Stock | 120.90 USD | -0.76% | -2.67% | +23.12% | -25.39% | 26.40 B USD |